99 related articles for article (PubMed ID: 22008484)
1. The effects of oral contraceptive use on muscle stiffness across the menstrual cycle.
Bell DR; Blackburn JT; Ondrak KS; Hackney AC; Hudson JD; Norcross MF; Padua DA
Clin J Sport Med; 2011 Nov; 21(6):467-73. PubMed ID: 22008484
[TBL] [Abstract][Full Text] [Related]
2. Acute effect of alcohol on estradiol, estrone, progesterone, prolactin, cortisol, and luteinizing hormone in premenopausal women.
Sarkola T; Mäkisalo H; Fukunaga T; Eriksson CJ
Alcohol Clin Exp Res; 1999 Jun; 23(6):976-82. PubMed ID: 10397281
[TBL] [Abstract][Full Text] [Related]
3. The correlations between estradiol, estrone, estriol, progesterone, and sex hormone-binding globulin and anterior cruciate ligament stiffness in healthy, active females.
Romani W; Patrie J; Curl LA; Flaws JA
J Womens Health (Larchmt); 2003 Apr; 12(3):287-98. PubMed ID: 12804359
[TBL] [Abstract][Full Text] [Related]
4. Changing hormone levels during the menstrual cycle affect knee laxity and stiffness in healthy female subjects.
Park SK; Stefanyshyn DJ; Loitz-Ramage B; Hart DA; Ronsky JL
Am J Sports Med; 2009 Mar; 37(3):588-98. PubMed ID: 19174550
[TBL] [Abstract][Full Text] [Related]
5. Measuring performance during the menstrual cycle: a model using oral contraceptives.
Redman LM; Weatherby RP
Med Sci Sports Exerc; 2004 Jan; 36(1):130-6. PubMed ID: 14707778
[TBL] [Abstract][Full Text] [Related]
6. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
Lebrun CM
Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
[TBL] [Abstract][Full Text] [Related]
7. Effect of the menstrual cycle on performance of intermittent, high-intensity shuttle running in a hot environment.
Sunderland C; Nevill M
Eur J Appl Physiol; 2003 Jan; 88(4-5):345-52. PubMed ID: 12527962
[TBL] [Abstract][Full Text] [Related]
8. Eating disorder pathology and menstrual cycle fluctuations in eating variables in oral contraceptive users and non-users.
McVay MA; Copeland AL; Geiselman PJ
Eat Behav; 2011 Jan; 12(1):49-55. PubMed ID: 21184973
[TBL] [Abstract][Full Text] [Related]
9. Does oral contraceptive use affect maximum force production in women?
Elliott KJ; Cable NT; Reilly T
Br J Sports Med; 2005 Jan; 39(1):15-9. PubMed ID: 15618333
[TBL] [Abstract][Full Text] [Related]
10. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
[TBL] [Abstract][Full Text] [Related]
11. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones].
Farkas M
Acta Pharm Hung; 1992; 62(1-2):17-30. PubMed ID: 1566635
[TBL] [Abstract][Full Text] [Related]
12. Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women.
Leonard AN; Shill AL; Thackray AE; Stensel DJ; Bishop NC
Eur J Appl Physiol; 2021 Mar; 121(3):793-801. PubMed ID: 33289860
[TBL] [Abstract][Full Text] [Related]
13. Menstrual cycle and oral contraceptives' effects on growth hormone response to sprinting.
Sunderland C; Tunaley V; Horner F; Harmer D; Stokes KA
Appl Physiol Nutr Metab; 2011 Aug; 36(4):495-502. PubMed ID: 21848445
[TBL] [Abstract][Full Text] [Related]
14. Effects of menstrual cycle phase and oral contraceptive use on verbal memory.
Mordecai KL; Rubin LH; Maki PM
Horm Behav; 2008 Aug; 54(2):286-93. PubMed ID: 18455727
[TBL] [Abstract][Full Text] [Related]
15. Effect of menstrual cycle phase on the concentration of bioavailable 17-beta oestradiol and testosterone and muscle strength.
Elliott KJ; Cable NT; Reilly T; Diver MJ
Clin Sci (Lond); 2003 Dec; 105(6):663-9. PubMed ID: 12848619
[TBL] [Abstract][Full Text] [Related]
16. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
Hietala M; Sandberg T; Borg A; Olsson H; Jernström H
Hum Reprod; 2007 Jan; 22(1):83-91. PubMed ID: 16920725
[TBL] [Abstract][Full Text] [Related]
17. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
18. Ventilatory control and acid-base regulation across the menstrual cycle in oral contraceptive users.
Nettlefold L; Jensen D; Janssen I; Wolfe LA
Respir Physiol Neurobiol; 2007 Aug; 158(1):51-8. PubMed ID: 17543591
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral contraceptive use on female sexual salivary hormones and indirect markers of muscle damage following eccentric cycling in women.
Mackay K; González C; Zbinden-Foncea H; Peñailillo L
Eur J Appl Physiol; 2019 Dec; 119(11-12):2733-2744. PubMed ID: 31686212
[TBL] [Abstract][Full Text] [Related]
20. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.
Paoletti AM; Orrù M; Lello S; Floris S; Ranuzzi F; Etzi R; Zedda P; Guerriero S; Fratta S; Sorge R; Mallarini G; Melis GB
Contraception; 2004 Oct; 70(4):293-8. PubMed ID: 15451333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
